Patents by Inventor Ki Jeong Lee

Ki Jeong Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11969707
    Abstract: The method for preparing a super absorbent polymer according to the present disclosure has a feature that it is possible to reduce the generation of a fine powder during production of the super absorbent polymer while maintaining excellent physical properties of the super absorbent polymer, including centrifuge retention capacity (CRC) and vortex removal time.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: April 30, 2024
    Assignee: LG Chem, Ltd.
    Inventors: Jaeyul Kim, Jong Hun Song, Gicheul Kim, Yoon Jae Min, Ki Hyun Kim, Seul Ah Lee, In Yong Jeong, Heechang Woo
  • Patent number: 11953066
    Abstract: The present disclosure relates to a brake disc including a braking part having a circular plate shape having a hollow portion and a plurality of coupling portions protruding and extending from an inner diameter surface thereof, and a hat part disposed in the hollow portion and having a plurality of insertion portions protruding laterally, in which the plurality of coupling portions is respectively coupled to the plurality of insertion portions, and the coupling portion of the braking part and the insertion portion of the hat part are joined to only one of an outboard portion or an inboard portion of the braking part. According to the present disclosure, it is possible to reduce noise occurring at a position at which the hat part and the braking part are coupled to each other and improve cooling performance.
    Type: Grant
    Filed: April 1, 2022
    Date of Patent: April 9, 2024
    Assignees: HYUNDAI MOTOR COMPANY, KIA CORPORATION, SEOHAN INDUSTRY CO., LTD.
    Inventors: Yoon-Cheol Kim, Kyung-Rok Choi, Sang-Bum Koh, Seong-Kweon Joo, Ki-Jeong Kim, Jae-Seok Lee
  • Patent number: 11956998
    Abstract: A display device includes: a first substrate including a pixel area and a transmissive area; a thin-film transistor on the first substrate; a planarization layer on the thin-film transistor; a first light emitting electrode on the planarization layer; a bank covering a part of the first light emitting electrode; a light emitting layer on the first light emitting electrode; and a second light emitting electrode on the light emitting layer and the bank. The transmissive area includes a transmissive hole penetrating the bank and the planarization layer.
    Type: Grant
    Filed: January 4, 2023
    Date of Patent: April 9, 2024
    Assignee: Samsung Display Co., Ltd.
    Inventors: Se Wan Son, Moo Soon Ko, Rae Young Gwak, Jin Seock Ma, Min Jeong Park, Ki Bok Yoo, So La Lee, Jin Goo Jung, Jong Won Chae, Ye Ji Han
  • Patent number: 11834683
    Abstract: The present invention is directed to an in vitro method of producing a recombinant AAV virion in a mammalian host cell that comprises a functional adenoviral E1A gene (e.g., a HEK 293T cell) and rAAV virions made by the method.
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: December 5, 2023
    Inventors: Huiren Zhao, Grace Ki Jeong Lee, Thomas Wolfe, Cherylene Plewa, Jackie Z. Sheng
  • Patent number: 11507227
    Abstract: A touch display device and a method of driving the same are disclosed. The touch display device includes: a touch display panel displaying an image and sensing a touch; a plurality of touch electrodes disposed on the touch display panel and divided into a plurality of blocks; a plurality of gate lines disposed on the touch display panel and overlapping the plurality of touch electrodes; and a touch display driving circuit supplying a common voltage to the plurality of touch electrodes and supplying a gate voltage to the plurality of gate lines, wherein the common voltage has a first voltage before and after a first compensation period corresponding to a high level period of the gate voltage supplied to one of the plurality of gate lines firstly overlapping one of the plurality of touch electrodes and has a second voltage lower than the first voltage during the first compensation period.
    Type: Grant
    Filed: October 5, 2021
    Date of Patent: November 22, 2022
    Assignee: LG Display Co., Ltd.
    Inventors: Kyoung-Seok Park, Ki-Jeong Lee, Hyun-Ho Park, Sung-Jin Um
  • Publication number: 20220206627
    Abstract: A touch display device and a method of driving the same are disclosed. The touch display device includes: a touch display panel displaying an image and sensing a touch; a plurality of touch electrodes disposed on the touch display panel and divided into a plurality of blocks; a plurality of gate lines disposed on the touch display panel and overlapping the plurality of touch electrodes; and a touch display driving circuit supplying a common voltage to the plurality of touch electrodes and supplying a gate voltage to the plurality of gate lines, wherein the common voltage has a first voltage before and after a first compensation period corresponding to a high level period of the gate voltage supplied to one of the plurality of gate lines firstly overlapping one of the plurality of touch electrodes and has a second voltage lower than the first voltage during the first compensation period.
    Type: Application
    Filed: October 5, 2021
    Publication date: June 30, 2022
    Inventors: Kyoung-Seok Park, Ki-Jeong Lee, Hyun-Ho Park, Sung-Jin Um
  • Publication number: 20210363498
    Abstract: Disclosed are an in vitro method of producing a recombinant AAV virion in a mammalian host cell that comprises a functional adenoviral E1A gene (e.g., a HEK 293 cell) and rAAV virions made by the method.
    Type: Application
    Filed: July 28, 2021
    Publication date: November 25, 2021
    Inventors: Huiren ZHAO, Grace Ki Jeong LEE, Thomas WOLFE, Cherylene PLEWA, Jackie Z. SHENG
  • Patent number: 11078464
    Abstract: The present invention is directed to an in vitro method of producing a recombinant AAV virion in a mammalian host cell that comprises a functional adenoviral E1A gene and rAAV virions made by the method. Host cells are transfected with varying ratios of plasmids comprising the E1A gene and virions.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: August 3, 2021
    Assignee: Amgen Inc.
    Inventors: Huiren Zhao, Grace Ki Jeong Lee, Thomas Wolfe, Cherylene Plewa, Jackie Z. Sheng
  • Patent number: 10585512
    Abstract: A touch display device includes: a timing controlling unit generating a touch synchronizing signal, an image data, a data controlling signal and a gate controlling signal; a micro controlling unit generating first to third selecting signals; a touch power unit including a MUX input part and a MUX part, the MUX input part deactivated during a display period and activated during a touch period, the MUX part generating a modified common voltage and first and second gate low voltages; a data driving unit generating a data voltage; a gate driving unit generating a modified gate voltage; and a touch display panel displaying an image during the display period and sensing a touch during the touch period.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: March 10, 2020
    Assignee: LG DISPLAY CO., LTD.
    Inventors: Ki-Jeong Lee, Yun-Jong Choi
  • Publication number: 20190263931
    Abstract: This invention generally pertains to antibodies and antigen-binding fragments thereof, e.g., humanized, chimeric, and human antibodies and antigen-binding fragments thereof, and fusion proteins, compositions containing such antibodies and antigen-binding fragments thereof and fusion proteins, wherein such antibodies and antigen-binding fragments thereof and fusion proteins specifically bind to MCT1, e.g., human or non-human MCT1 and antagonize, inhibit or block one or more MCT1-associated functions in vitro and/or in vivo. The invention also relates to therapeutic and diagnostic uses of these anti-MCT1 antibodies, antigen-binding fragments, fusion proteins and compositions containing optionally wherein these anti-MCT1 antibodies, antigen-binding fragments, fusion proteins and compositions containing are used in therapeutic regimens that further include the administration of other therapeutic agents, e.g., mitochondrial inhibitors and/or biguanides or small molecule MCT1 inhibitors.
    Type: Application
    Filed: January 4, 2019
    Publication date: August 29, 2019
    Inventors: Jay L. Rothstein, Grace Ki Jeong Lee, Kimberly P. Shigenaka, Marcia Gordon, Kim Quon, Philipe Gobeil, Catherine Carriere, Sergey Seregin, Yong Wang, Raphael D. Levy, Jordon K. Wang
  • Patent number: 10360409
    Abstract: A system for managing smart cards is disclosed. A system for managing smart cards, comprises a key management server for managing at least one master key used to grant the right to manage a smart card which operates in conjunction with a mobile terminal, and generates an installation key, used to grant the right to install or store a predetermined applet, based on the master key, and a card management server for receiving the generated installation key, and provides the applet to the mobile terminal based on the installation key in response to a request from the mobile terminal.
    Type: Grant
    Filed: June 18, 2008
    Date of Patent: July 23, 2019
    Assignee: KT CORPORATION
    Inventors: Young Chual Park, Tae Joon Yang, Ki Jeong Lee
  • Publication number: 20180307357
    Abstract: A touch display device includes: a timing controlling unit generating a touch synchronizing signal, an image data, a data controlling signal and a gate controlling signal; a micro controlling unit generating first to third selecting signals; a touch power unit including a MUX input part and a MUX part, the MUX input part deactivated during a display period and activated during a touch period, the MUX part generating a modified common voltage and first and second gate low voltages; a data driving unit generating a data voltage; a gate driving unit generating a modified gate voltage; and a touch display panel displaying an image during the display period and sensing a touch during the touch period.
    Type: Application
    Filed: April 20, 2018
    Publication date: October 25, 2018
    Inventors: Ki-Jeong LEE, Yun-Jong CHOI
  • Patent number: 9688759
    Abstract: Compositions for treating disorders of iron homeostasis are provided. More particularly, anti-ferroportin antibodies, compositions containing such antibodies, corresponding nucleic acids, vectors and host cells, and methods of making such antibodies are provided.
    Type: Grant
    Filed: September 25, 2015
    Date of Patent: June 27, 2017
    Assignee: Amgen, Inc.
    Inventors: Tara Arvedson, Gregory Dyas, James B. Rottman, Barbra Sasu, Xiao-juan Bi, Grace Ki Jeong Lee, Jackie Z. Sheng
  • Publication number: 20160247858
    Abstract: An electronic device includes a semiconductor unit.
    Type: Application
    Filed: June 11, 2015
    Publication date: August 25, 2016
    Inventors: Beom-Yong KIM, Ki-Jeong LEE
  • Publication number: 20160222356
    Abstract: Disclosed are an in vitro method of producing a recombinant AAV virion in a mammalian host cell that comprises a functional adenoviral E1A gene (e.g., a HEK 293 cell) and rAAV virions made by the method.
    Type: Application
    Filed: August 28, 2014
    Publication date: August 4, 2016
    Applicant: AMGEN INC.
    Inventors: Huiren ZHAO, Ki Jeong LEE, Thomas WOLFE, Cherylene PLEWA, Jackie Z. SHENG
  • Patent number: 9325668
    Abstract: Disclosed herein is a system and method for providing Over-The-Air (OTA) service. The system according to the present invention includes an OTA server for, when OTA data is requested by a mobile terminal, encrypting the requested OTA data using a preset OTA key depending on the type of the requested OTA data, and creating a message for providing the encrypted OTA data; and a message center for receiving the created message, and sending the created message to the mobile terminal.
    Type: Grant
    Filed: June 18, 2008
    Date of Patent: April 26, 2016
    Assignee: KT CORPORATION
    Inventors: Young Chual Park, Tae Joon Yang, Ki Jeong Lee
  • Publication number: 20160083470
    Abstract: Compositions for treating disorders of iron homeostasis are provided. More particularly, anti-ferroportin antibodies, compositions containing such antibodies, corresponding nucleic acids, vectors and host cells, and methods of making such antibodies are provided.
    Type: Application
    Filed: September 25, 2015
    Publication date: March 24, 2016
    Applicant: AMGEN INC.
    Inventors: Tara ARVEDSON, Gregory DYAS, James B. ROTTMAN, Barbra SASU, Xiao-juan BI, Grace Ki Jeong LEE, Jackie Z. SHENG
  • Patent number: 9175078
    Abstract: Compositions for treating disorders of iron homeostasis are provided. More particularly, anti-ferroportin antibodies, compositions containing such antibodies, corresponding nucleic acids, vectors and host cells, and methods of making such antibodies are provided.
    Type: Grant
    Filed: January 23, 2009
    Date of Patent: November 3, 2015
    Assignee: AMGEN INC.
    Inventors: Tara Arvedson, Gregory Dyas, James B. Rottman, Barbra Sasu, Xiao-juan Bi, Grace Ki Jeong Lee, Jackie Z. Sheng
  • Publication number: 20140286953
    Abstract: The invention relates to purified, correctly folded hepcidin, antibodies that bind hepcidin, and methods of making and using such materials. Also provide are methods of treated hepcidin-related disorders.
    Type: Application
    Filed: December 11, 2013
    Publication date: September 25, 2014
    Applicant: Amgen Inc.
    Inventors: Barbra Sasu, Mitsuru Haniu, Thomas Charles Boone, Xiao-juan Bi, Grace Ki Jeong Lee, Tara Arvedson, Aaron George Winters, Keegan Cooke, Jackie Z. Sheng
  • Publication number: 20140189893
    Abstract: Methods of identifying compounds that specifically modulate the interaction of FGFR1 and ?-Klotho are disclosed. Identified compounds can be useful in treating metabolic diseases and disorders that involve the interaction of FGFR1 and ?-Klotho. In various embodiments the metabolic disease or disorder is diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy.
    Type: Application
    Filed: February 20, 2012
    Publication date: July 3, 2014
    Applicant: AMGEN INC.
    Inventors: Yang Li, Xinle Wu, Hongfei Ge, Helene Baribault, Bryan Lemon, Jackie Z. Sheng, Steven Vonderfecht, Jennifer Veronica Weiszmann, Jonitha Gardner, Grace Ki Jeong Lee